Diana M. Gibb
Medical Research Council Trials Unit
London
UK
Name/email consistency: high
- Immunologic changes during unplanned treatment interruptions of highly active antiretroviral therapy in children with human immunodeficiency virus type 1 infection. Gibb, D.M., Duong, T., Leclezio, V.A., Walker, A.S., Verweel, G., Dunn, D.T. Pediatr. Infect. Dis. J. (2004)
- Adherence to prescribed antiretroviral therapy in human immunodeficiency virus-infected children in the PENTA 5 trial. Gibb, D.M., Goodall, R.L., Giacomet, V., McGee, L., Compagnucci, A., Lyall, H. Pediatr. Infect. Dis. J. (2003)
- Decline in mortality, AIDS, and hospital admissions in perinatally HIV-1 infected children in the United Kingdom and Ireland. Gibb, D.M., Duong, T., Tookey, P.A., Sharland, M., Tudor-Williams, G., Novelli, V., Butler, K., Riordan, A., Farrelly, L., Masters, J., Peckham, C.S., Dunn, D.T. BMJ (2003)
- Evolution of antiretroviral phenotypic and genotypic drug resistance in antiretroviral-naive HIV-1-infected children treated with abacavir/lamivudine, zidovudine/lamivudine or abacavir/zidovudine, with or without nelfinavir (the PENTA 5 trial). Gibb, D.M., Walker, A.S., Kaye, S., De Rossi, A., Ait-Khaled, M., Pillay, D., Muñoz-Fernandez, M.A., Loveday, C., Compagnucci, A., Dunn, D.T., Babiker, A.G. Antivir. Ther. (Lond.) (2002)
- Active surveillance of hepatitis C infection in the UK and Ireland. Gibb, D.M., Neave, P.E., Tookey, P.A., Ramsay, M., Harris, H., Balogun, K., Goldberg, D., Mieli-Vergani, G., Kelly, D. Arch. Dis. Child. (2000)
- Antenatal screening for HIV infection. Gibb, D.M. AIDS. Patient. Care. STDS (2000)
- Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission. Gibb, D.M., Goodall, R.L., Dunn, D.T., Healy, M., Neave, P., Cafferkey, M., Butler, K. Lancet (2000)
- Interventions to reduce mother-to-child transmission of HIV infection: new developments and current controversies. Gibb, D.M., Tess, B.H. AIDS (1999)









